Esophageal Carcinoma Clinical Trials in Shanghai
2 recruitingShanghai, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University452 enrolled1 locationNCT06964568
Recruiting
The Study on the Mechanism of Radiotherapy-elicited Immune Response
RadiotherapyEsophageal Carcinoma Salivary Gland Type
Fudan University200 enrolled1 locationNCT06393140